combination chemotherapy Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials

Male only (2)
Female only (18)
Any (153)

Phase 1 (16)
Phase 2 (85)
Phase 3 (28)
Phase 4 (7)
Phase 1/2 (14)
Phase 2/3 (4)
Unknown (19)

Interventional (165)
Observational (6)

National Cancer Institute (NCI) (13)
M.D. Anderson Cancer Center (9)
Yonsei University (4)
Children's Oncology Group (3)
Fudan University (3)
Jonsson Comprehensive Cancer Center (3)
University of Leicester (3)
University of Washington (3)
Affiliated Hospital to Academy of Military Medical Sciences (2)
Asan Medical Center (2)
Barbara Ann Karmanos Cancer Institute (2)
Emory University (2)
European Paediatric Soft Tissue Sarcoma Study Group (2)
Gruppo Oncologico Italiano di Ricerca Clinica (2)
IRCCS San Raffaele (2)
International Group of Endovascular Oncology (2)
Japan Rhabdomyosarcoma Study Group (2)
Medical Research Council (2)
National Taiwan University Hospital (2)
Northwestern University (2)
Samsung Medical Center (2)
Simcere Pharmaceutical Co., Ltd (2)
University Hospital Southampton NHS Foundation Trust. (2)
University of Southampton (2)
AC Camargo Cancer Center (1)
AIO-Studien-gGmbH (1)
Academic Thoracic Oncology Medical Investigators Consortium (1)
Alexander Valdman (1)
All Ireland Cooperative Oncology Research Group (1)
Alliance for Clinical Trials in Oncology (1)
Associazione Italiana per lo Studio del Pancreas (1)
Azienda Ospedaliera - Universitaria di Modena (1)
Baylor College of Medicine (1)
Bayside Health (1)
Beijing Cancer Hospital (1)
Bio-Path Holdings, Inc. (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
Case Comprehensive Cancer Center (1)
Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz (1)
Centre Hospitalier Universitaire de Besancon (1)
Children's Cancer and Leukaemia Group (1)
City of Hope Medical Center (1)
Columbia University (1)
Cooperative Study Group A for Hematology (1)
Duke University (1)
Eisai Co., Ltd. (1)
Federation Francophone de Cancerologie Digestive (1)
Fred Hutchinson Cancer Research Center (1)
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany (1)
Groupe Francais De Pneumo-Cancerologie (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
Hebei Medical University Fourth Hospital (1)
Immunicom Inc (1)
Inna Chen, MD (1)
Institut Bergonié (1)
Institut du Cancer de Montpellier - Val d'Aurelle (1)
Janssen Research & Development, LLC (1)
Jiangsu Alphamab Biopharmaceuticals Co., Ltd (1)
Jiuda Zhao (1)
Karyopharm Therapeutics Inc (1)
King Abdullah Medical City (1)
Korean Cancer Study Group (1)
Loyola University (1)
Ludwig-Maximilians - University of Munich (1)
Masonic Cancer Center, University of Minnesota (1)
Mayo Clinic (1)
McGill University (1)
Medical University of Vienna (1)
Mercy Medical Center (1)
Mitchell Cairo (1)
National Cancer Institute, Naples (1)
Novartis Pharmaceuticals (1)
OHSU Knight Cancer Institute (1)
Odette Cancer Centre at Sunnybrook (1)
Pancreatic Cancer Action Network (1)
Peking Union Medical College Hospital (1)
Per Pfeiffer (1)
PrECOG, LLC. (1)
Pusan National University Yangsan Hospital (1)
ROGER S MD KERESZTES (1)
Rachael A Safyan, MD (1)
Raghu Nandan, M.D., Inc (1)
SCRI Development Innovations, LLC (1)
Shandong Provincial Hospital (1)
Sichuan Cancer Hospital and Research Institute (1)
Southern Italy Cooperative Oncology Group (1)
St. Olavs Hospital (1)
Taizhou Mabtech Pharmaceutical Co.,Ltd (1)
Tata Memorial Hospital (1)
Technische Universität München (1)
Tehran University of Medical Sciences (1)
Thai Gynecologic Oncology Collaborative Group (1)
The Clatterbridge Cancer Centre NHS Foundation Trust (1)
The Fourth Affiliated Hospital of Zhejiang University School of Medicine (1)
The University of Hong Kong (1)
Therapeutic Advances in Childhood Leukemia Consortium (1)
Tianjin Medical University Cancer Institute and Hospital (1)
University College London Hospitals (1)
University Hospital Heidelberg (1)
University Hospital, Bonn (1)

No (171)
Yes (2)

Updated trials (16)

I am/have/had

I am/have/hadresidual tumor

I am/have/hadacute promyelocytic leukemia

I am/have/hadremission

I am/have/hadhigh grade b-cell lymphoma

I am/have/hadEGFR

I am/have/hadpdac

I am/have/hadadjuvant chemotherapy

I am/have/hadchemotherapy regimen

I am/have/hadacute leukemia

I am/have/hadneutrophil count

I am/have/hadesophageal cancer

I am/have/hadadjuvant therapy

I am/have/hadcombination chemotherapy

I am/have/hadadenocarcinoma of rectum

I am/have/hadlymphoma

I am/have/hadadvanced breast cancer

I am/have/hadbone marrow procedure

I am/have/hadcell transplantation

I am/have/hadchronic lymphocytic leukemia

I am/have/hadbladder cancer

added new label for I am/have/had

I am looking for

I am looking forfluorouracil

I am looking forcapecitabine

I am looking forthioguanine

I am looking formitoxantrone

I am looking fordactinomycin

I am looking fordoxorubicin

I am looking forconjugated bilirubin

I am looking forgranulocyte colony stimulating factor

I am looking forendocrine therapy

I am looking foranthracyclines

I am looking forplatinum doublet

I am looking forwarfarin

I am looking fortamoxifen

I am looking forepidermal growth factor

I am looking formethotrexate

I am looking forvinblastine

I am looking forcyclosporine

I am looking foriobenguane

I am looking forleucovorin

I am looking forcalcium

added new label for I am looking for

Advanced Filters

Found 173 clinical trials

featured

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For pediatric ages
For all genders
Recruiting

AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer

400 views
07 Nov, 2020
1 location

featured

For pediatric ages
For all genders
Recruiting

AALL0434: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

170 views
08 Nov, 2020
1 location

Phase 3
For pediatric ages
For Seniors
Recruiting in 1000s
Interventional Study
For all genders
Family Medicine
Recruiting

Combination Chemotherapy in Treating Patients With Esophageal Cancer

yet known which regimen of combination chemotherapy is more effective in treating esophageal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of

tumor cells

combination chemotherapy

epirubicin

cancer

fluorouracil

31 views
07 Nov, 2020
1 location

For pediatric ages
For adults
Recruiting in 100s
Interventional Study
For all genders
Hematology
Recruiting

Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

(combination chemotherapy) may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating acute lymphoblastic leukemia. PURPOSE: This randomized

methotrexate

combination chemotherapy

cytarabine

dexamethasone

cancer

1 views
07 Nov, 2020
5 locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
For all genders
Musculoskeletal Diseases
Recruiting

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

(combination chemotherapy) may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating rhabdomyosarcoma. PURPOSE: This randomized phase III

tumor cells

combination chemotherapy

cancer chemotherapy

conventional surgery

ifosfamide

103 views
07 Nov, 2020
9 locations

Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
For all genders
Hematology
Recruiting

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

(combination chemotherapy) may kill more cancer cells. A donor stem cell transplant may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-tumor effect

methotrexate

combination chemotherapy

cytarabine

cancer

dexamethasone

0 views
07 Nov, 2020
1 location

Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
For Females
Family Medicine
Recruiting

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I Stage II or Stage III HER2-Positive Breast Cancer

substances to them. It is not yet known which regimen of combination chemotherapy given together with trastuzumab is most effective in treating breast cancer. PURPOSE: This randomized phase III

adjuvant therapy

tumor cells

epirubicin

her2/neu-positive breast cancer

aromatase inhibitor

33 views
07 Nov, 2020
1 location

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For all genders
Family Medicine
Recruiting

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

dividing. Giving bevacizumab together with combination chemotherapy may kill more tumor cells. PURPOSE: This phase III trial is studying how well giving induction therapy with bevacizumab

adjuvant therapy

tumor cells

tumor growth

combination chemotherapy

fluorouracil

7 views
07 Nov, 2020
1 location

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
For all genders
Musculoskeletal Diseases
Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation Radiation Therapy and/or Surgery in Treating Patients With Ewing's Sarcoma

. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy and kill more tumor cells. It is not yet known if combination chemotherapy is more effective with or

tumor cells

combination chemotherapy

cancer chemotherapy

conventional surgery

ifosfamide

410 views
07 Nov, 2020
4 locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
For all genders
Neurology
Recruiting

Observation Combination Chemotherapy Radiation Therapy and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

until it progresses. In this case, observation may be sufficient. It is not yet known whether observation is more effective than combination chemotherapy, radiation therapy, and/or autologous

topotecan

x-rays

melphalan

doxorubicin

vindesine

30 views
07 Nov, 2020
28 locations